Rab K. Prinjha
- Molecular Biology top 1%
- Hematology top 0.5%
- Immunology top 2%
- Cancer Research top 2%
- Oncology top 5%
- Co-authors
- Alexander TarakhovskyDavid F. ToughChun‐wa ChungUwe SchaeferScott DewellKevin LeeKate L. JeffreyIvan Marazzi
- Topics
- Protein Degradation and Inhibitors (60 papers)Multiple Myeloma Research and Treatments (28 papers)Ubiquitin and proteasome pathways (25 papers)
- Cited by
- HematologyVirologyMolecular Biology
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Rab K. Prinjha
104 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 4.9k
- Hematology 1.3k
- Immunology 1.3k
- Cancer Research 906
- Oncology 697
Countries citing papers authored by Rab K. Prinjha
This map shows the geographic impact of Rab K. Prinjha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rab K. Prinjha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rab K. Prinjha more than expected).
Fields of papers citing papers by Rab K. Prinjha
This network shows the impact of papers produced by Rab K. Prinjha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rab K. Prinjha. The network helps show where Rab K. Prinjha may publish in the future.
Co-authorship network of co-authors of Rab K. Prinjha
This figure shows the co-authorship network connecting the top 25 collaborators of Rab K. Prinjha. A scholar is included among the top collaborators of Rab K. Prinjha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rab K. Prinjha. Rab K. Prinjha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 20 | |
| 8 | 4 | |
| 9 | 5 | |
| 10 | 32 | |
| 11 | 73 | |
| 12 | 13 | |
| 13 | 15 | |
| 14 | 38 | |
| 15 | 23 | |
| 16 | 30 | |
| 17 | 119 | |
| 18 | 132 | |
| 19 | 51 | |
| 20 | 77 |
About Rab K. Prinjha
Rab K. Prinjha is a scholar working on Hematology, Virology and Molecular Biology, having authored 106 papers that have together received 6.7k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (60 papers), Multiple Myeloma Research and Treatments (28 papers) and Ubiquitin and proteasome pathways (25 papers). The work is most often cited by research in Hematology (1.3k citations), Virology (415 citations) and Molecular Biology (4.9k citations). Rab K. Prinjha has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Alexander Tarakhovsky, David F. Tough, Chun‐wa Chung, Uwe Schaefer, Scott Dewell, Kevin Lee, Kate L. Jeffrey, Ivan Marazzi, Rohit Chandwani and Charles M. Rice. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.